This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Pierre Fabre Medicament. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014
Title: Fadila Derguini: Innovator in Anticancer Compounds
Introduction
Fadila Derguini is a notable inventor based in Toulouse, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer activity. Her work is characterized by a commitment to advancing medical science and improving treatment options for patients.
Latest Patents
Fadila Derguini holds a patent for ngCycloartanone derivatives with anticancer activity. The present invention relates to a compound of the following formula (I) or to a pharmaceutically acceptable salt thereof. This invention also includes pharmaceutical compositions that utilize these compounds and their application as a drug, specifically for treating proliferative diseases such as cancer. She has 1 patent to her name.
Career Highlights
Throughout her career, Fadila has worked with prominent organizations such as Pierre Fabre Medicament and the Centre National de la Recherche Scientifique. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Fadila has collaborated with notable colleagues, including Yves Guminski and Frédéric Cantagrel. These partnerships have enriched her research and expanded the impact of her inventions.
Conclusion
Fadila Derguini is a pioneering inventor whose work in anticancer compounds demonstrates her dedication to improving healthcare. Her contributions to the field are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile